This handbook serves as a portable reference that utilizes evidence-based medicine as the basis for practical treatment recommendations and guidelines in radiation oncology. The book is designed for quick reference, with concise clinical chapters, organized by body site, providing easy access to critical information. Important "pearls" of epidemiology, anatomy, pathology, and clinical presentation are highlighted. Key facets of the work-up are listed, followed by staging and risk classification systems. Discussion of treatment recommendations is highly specific, based on stage, histology, and risk classification. Brief summaries of key trials and studies provide support and rationale for the recommendations. Practical guidelines for radiation techniques are described. Each chapter concludes with a review of possible complications and outlines follow-up guidelines. A comprehensive section of appendices allows quick reference to information on performance status scales, radionucleotides used in brachytherapy, radiation safety, tumor markers, immunophenotyping and cytogenetics, and commonly prescribed drugs.
| Preface |
|
v | |
| Contributors |
|
ix | |
|
|
|
2 | (13) |
|
|
|
15 | (40) |
|
3 Cancer and Benign Diseases of the Eye and Orbit |
|
|
55 | (15) |
|
|
|
70 | (4) |
|
|
|
74 | (6) |
|
6 Nasal Cavity and Paranasal Sinus Cancer |
|
|
80 | (6) |
|
|
|
86 | (9) |
|
8 Cancer of the Lip and Oral Cavity |
|
|
95 | (17) |
|
9 Cancer of the Larynx and Hypopharynx |
|
|
112 | (14) |
| 10 Salivary Gland Tumors |
|
126 | (10) |
| 11 Thyroid Cancer |
|
136 | (11) |
| 12 Unusual Neoplasms of the Head and Neck |
|
147 | (6) |
| 13 Small Cell Lung Cancer |
|
153 | (4) |
| 14 Non-Small Cell Lung Cancer |
|
157 | (17) |
| 15 Mesothelioma and Thymoma |
|
174 | (8) |
| 16 Breast Cancer |
|
182 | (26) |
| 17 Esophageal Cancer |
|
208 | (11) |
| 18 Gastric Cancer |
|
219 | (11) |
| 19 Pancreatic Cancer |
|
230 | (11) |
| 20 Hepatobiliary Cancer |
|
241 | (14) |
| 21 Colorectal Cancer |
|
255 | (10) |
| 22 Anal Cancer |
|
265 | (13) |
| 23 Renal Cell Carcinoma |
|
278 | (6) |
| 24 Bladder Cancer |
|
284 | (9) |
| 25 Prostate Cancer |
|
293 | (26) |
| 26 Cancer of the Penis |
|
319 | (6) |
| 27 Testicular Cancer |
|
325 | (10) |
| 28 Cervical Cancer |
|
335 | (13) |
| 29 Endometrial Cancer |
|
348 | (10) |
| 30 Ovarian Cancer |
|
358 | (10) |
| 31 Vaginal Cancer |
|
368 | (7) |
| 32 Vulvar Cancer |
|
375 | (6) |
| 33 Hodgkin's Lymphoma |
|
381 | (13) |
| 34 Non-Hodgkin's Lymphoma |
|
394 | (8) |
| 35 Cutaneous Lymphomas |
|
402 | (7) |
| 36 Multiple Myeloma and Plasmacytoma |
|
409 | (7) |
| 37 Bone Tumors |
|
416 | (7) |
| 38 Soft Tissue Sarcoma |
|
423 | (9) |
| 39 Pediatric (Non-CNS) Tumors |
|
432 | (40) |
| 40 Palliative Care |
|
472 | (14) |
| Abbreviations |
|
486 | (6) |
| Appendixes |
|
492 | (21) |
|
A. Performance Status Scales |
|
|
492 | (1) |
|
B. Radionucleotides Used in Brachytherapy |
|
|
493 | (1) |
|
|
|
493 | (2) |
|
D. Tumor Markers, Immunophenotyping, and Cytogenetics |
|
|
495 | (3) |
|
E. Commonly Prescribed Drugs |
|
|
498 | (15) |
| Index |
|
513 | |